Antigenic peptides recognized by T lymphocytes from AIDS viral envelope-immune humans
- PMID: 2457809
- DOI: 10.1038/334706a0
Antigenic peptides recognized by T lymphocytes from AIDS viral envelope-immune humans
Abstract
T-lymphocyte immunity is likely to be an important component of the immune defence against the AIDS virus, because helper T cells are necessary for the antibody response as well as the cytotoxic response. We have previously predicted two antigenic sites of the viral envelope protein gp120 likely to be recognized by T lymphocytes, based on their ability to fold as amphipathic helices, and have demonstrated that these are recognized by T cells of mice immunized with gp120 (ref. 1). A peptide corresponding to one of these sites can also be induce immunity in mice to the whole gp120 protein. Because many clinically healthy seropositive blood donors have already lost their T-cell proliferative response to specific antigen, we tested the response to these synthetic peptides of lymphocytes from 14 healthy human volunteers who had been immunized with a recombinant vaccinia virus containing the AIDS viral envelope gene and boosted with a recombinant fragment. Eight of the 14 responded to one peptide, and four to the other peptide, not included in the boost. These antigenic sites recognized by human T cells may be useful components of a vaccine against AIDS. We also found a correlation between boosting with antigen-antibody complexes (compared to free antigen) and higher stimulation indices, suggesting a more effective method of immunization.
Similar articles
-
Construction of peptides encompassing multideterminant clusters of human immunodeficiency virus envelope to induce in vitro T cell responses in mice and humans of multiple MHC types.J Clin Invest. 1991 Sep;88(3):876-84. doi: 10.1172/JCI115389. J Clin Invest. 1991. PMID: 1715888 Free PMC article.
-
Immunization with subunit human immunodeficiency virus vaccine generates stronger T helper cell immunity than natural infection.Eur J Immunol. 1991 Jun;21(6):1345-9. doi: 10.1002/eji.1830210603. Eur J Immunol. 1991. PMID: 1845391
-
Efficient CD8+ T cell response to the HIV-env V3 loop epitope from multiple virus isolates by a DNA prime/vaccinia virus boost (rWR and rMVA strains) immunization regime and enhancement by the cytokine IFN-gamma.Virus Res. 2004 Sep 15;105(1):11-22. doi: 10.1016/j.virusres.2004.04.008. Virus Res. 2004. PMID: 15325077
-
Characterization of CD4 glycoprotein determinant-HIV envelope protein interactions: perspectives for analog and vaccine development.Crit Rev Immunol. 1988;8(4):315-39. Crit Rev Immunol. 1988. PMID: 2850890 Review.
-
Structural features of T-cell recognition: applications to vaccine design.Philos Trans R Soc Lond B Biol Sci. 1989 Jun 12;323(1217):535-44. doi: 10.1098/rstb.1989.0033. Philos Trans R Soc Lond B Biol Sci. 1989. PMID: 2474171 Review.
Cited by
-
Enhanced proliferative cellular responses to HIV-1 V3 peptide and gp120 following immunization with V3:Ty virus-like particles.Immunology. 1992 Nov;77(3):315-21. Immunology. 1992. PMID: 1362183 Free PMC article.
-
Early induction and maintenance of Env-specific T-helper cells following human immunodeficiency virus type 1 infection.J Virol. 2003 Feb;77(4):2663-74. doi: 10.1128/jvi.77.4.2663-2674.2003. J Virol. 2003. PMID: 12552005 Free PMC article.
-
Human immunodeficiency virus type 1 major neutralizing determinant exposed on hepatitis B surface antigen particles is highly immunogenic in primates.J Virol. 1992 Apr;66(4):2570-6. doi: 10.1128/JVI.66.4.2570-2576.1992. J Virol. 1992. PMID: 1548782 Free PMC article.
-
T-cell responses to predicted amphipathic peptides of varicella-zoster virus glycoproteins II and IV.J Virol. 1990 Feb;64(2):651-5. doi: 10.1128/JVI.64.2.651-655.1990. J Virol. 1990. PMID: 2153231 Free PMC article.
-
Immunogenic targeting of recombinant peptide vaccines to human antigen-presenting cells by chimeric anti-HLA-DR and anti-surface immunoglobulin D antibody Fab fragments in vitro.J Virol. 1995 Apr;69(4):2357-65. doi: 10.1128/JVI.69.4.2357-2365.1995. J Virol. 1995. PMID: 7533857 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical